Trial Profile
A long-term study to evaluate the effects of olmesartan on cerebral perfusion and cognitive function in post-stroke patients with hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 21 Dec 2015 New trial record